IL6 and COVID-19: In a meta-analysis, the mean IL-6 level in severe COVID-19 patients was 2.9 fold higher than in non-severe patients, and elevated IL-6 was correlated with adverse clinical outcomes such as intensive care unit (ICU) admission, ARDS, and death [73].